Document/ExhibitDescriptionPagesSize
1: 10-Q Quarterly Report HTML 2.71M
2: EX-10.2 Material Contract HTML 2.14M
3: EX-10.3 Material Contract HTML 30K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 28K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 29K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 26K
7: EX-32.2 Certification -- §906 - SOA'02 HTML 26K
13: R1 Cover Page HTML 77K
14: R2 Consolidated Balance Sheets HTML 135K
15: R3 Consolidated Balance Sheets (Parenthetical) HTML 38K
16: R4 Unaudited Consolidated Statements of Income HTML 102K
17: R5 Unaudited Consolidated Statements of Comprehensive HTML 52K
Income
18: R6 Unaudited Consolidated Statements of Stockholders' HTML 72K
Equity
19: R7 Unaudited Consolidated Statements of Cash Flows HTML 131K
20: R8 Summary of Significant Accounting Policies HTML 128K
21: R9 Accounts and Other Receivables HTML 47K
22: R10 Fair Value Measurements HTML 93K
23: R11 Stockholders' Equity HTML 32K
24: R12 Stock-Based Compensation HTML 69K
25: R13 Acquisitions HTML 83K
26: R14 Goodwill and Other Intangibles HTML 62K
27: R15 Debt HTML 46K
28: R16 Income Taxes HTML 60K
29: R17 Earnings Per Share HTML 45K
30: R18 Segments HTML 222K
31: R19 Commitments and Contingencies HTML 35K
32: R20 Derivative Financial Instruments and Hedging HTML 93K
Activities
33: R21 Accumulated Other Comprehensive Loss (Aocl) HTML 59K
34: R22 Summary of Significant Accounting Policies HTML 66K
(Policies)
35: R23 Summary of Significant Accounting Policies HTML 151K
(Tables)
36: R24 Accounts and Other Receivables (Tables) HTML 47K
37: R25 Fair Value Measurements (Tables) HTML 84K
38: R26 Stock-Based Compensation (Tables) HTML 74K
39: R27 Acquisitions (Tables) HTML 78K
40: R28 Goodwill and Other Intangibles (Tables) HTML 66K
41: R29 Debt (Tables) HTML 40K
42: R30 Income Taxes (Tables) HTML 58K
43: R31 Earnings Per Share (Tables) HTML 44K
44: R32 Segments (Tables) HTML 217K
45: R33 Derivative Financial Instruments and Hedging HTML 130K
Activities (Tables)
46: R34 Accumulated Other Comprehensive Loss (Aocl) HTML 59K
(Tables)
47: R35 Summary of Significant Accounting Policies - HTML 31K
Foreign Currency Translation (Details)
48: R36 Summary of Significant Accounting Policies - HTML 73K
Narrative (Details)
49: R37 Summary of Significant Accounting Policies - HTML 105K
Disaggregation of Revenue (Details)
50: R38 Summary of Significant Accounting Policies - HTML 49K
Schedule of Spot Trades (Details)
51: R39 Accounts and Other Receivables - Company's HTML 41K
Accounts Receivable and Securitized Accounts
Receivable (Details)
52: R40 Accounts and Other Receivables - Additional HTML 29K
Information (Details)
53: R41 Accounts and Other Receivables - Allowance for HTML 36K
Doubtful Accounts Related to Accounts Receivable
(Details)
54: R42 Fair Value Measurements - Financial Assets and HTML 87K
Liabilities Measured at Fair Value (Details)
55: R43 Stockholders' Equity - Repurchase Program HTML 51K
(Details)
56: R44 Stock-Based Compensation - Summary of Expense HTML 32K
Related to Share-Based Payments (Details)
57: R45 Stock-Based Compensation - Additional Information HTML 32K
(Details)
58: R46 Stock-Based Compensation - Summary of Total HTML 34K
Unrecognized Compensation Cost Related to
Stock-Based Compensation (Details)
59: R47 Stock-Based Compensation - Summary of Changes in HTML 67K
Number of Shares of Common Stock Under Option
(Details)
60: R48 Stock-Based Compensation - Summary of Changes in HTML 49K
Number of Shares of Restricted Stock and
Restricted Stock Units (Details)
61: R49 Acquisitions - Additional Information (Details) HTML 69K
62: R50 Acquisitions - Summary of Purchase Price HTML 85K
Allocation (Details)
63: R51 Acquisitions - Summary of Preliminary Estimated HTML 77K
Fair Value of Intangible Assets Acquired and the
Related Estimated Useful Lives (Details)
64: R52 Goodwill and Other Intangibles - Summary of HTML 36K
Changes in Goodwill by Reportable Business Segment
(Details)
65: R53 Goodwill and Other Intangibles - Schedule of Other HTML 49K
Intangibles (Details)
66: R54 Goodwill and Other Intangibles - Additional HTML 29K
Information (Details)
67: R55 Debt - Summary of Debt Instruments (Details) HTML 50K
68: R56 Debt - Narrative (Details) HTML 54K
69: R57 Income Taxes - Summary of Provision for Income HTML 91K
Taxes and U.S. Federal Tax Rate (Details)
70: R58 Earnings Per Share - Summary of Earnings Per HTML 59K
Share, Basic and Diluted (Detail)
71: R59 Earnings Per Share - Additional Information HTML 32K
(Detail)
72: R60 Segments - Additional Information (Detail) HTML 29K
73: R61 Segments - Schedule of Company's Segment Results HTML 82K
(Detail)
74: R62 Derivative Financial Instruments and Hedging HTML 35K
Activities - Schedule of Notional Amounts
(Details)
75: R63 Derivative Financial Instruments and Hedging HTML 54K
Activities - Schedule of Fair Value by Balance
Sheet Location (Details)
76: R64 Derivative Financial Instruments and Hedging HTML 38K
Activities - Schedule of Derivative Assets and
Liabilities at Fair Value (Details)
77: R65 Derivative Financial Instruments and Hedging HTML 40K
Activities - Additional Information (Details)
78: R66 Derivative Financial Instruments and Hedging HTML 35K
Activities - Schedule of Cash Flow Hedge Notional
Amounts (Details)
79: R67 Derivative Financial Instruments and Hedging HTML 46K
Activities - Schedule of Fair Value and Balance
Sheet Location (Details)
80: R68 Accumulated Other Comprehensive Loss (Aocl) HTML 56K
(Details)
83: XML IDEA XML File -- Filing Summary XML 153K
81: XML XBRL Instance -- flt-20220630_htm XML 3.31M
82: EXCEL IDEA Workbook of Financial Reports XLSX 162K
9: EX-101.CAL XBRL Calculations -- flt-20220630_cal XML 237K
10: EX-101.DEF XBRL Definitions -- flt-20220630_def XML 572K
11: EX-101.LAB XBRL Labels -- flt-20220630_lab XML 1.57M
12: EX-101.PRE XBRL Presentations -- flt-20220630_pre XML 982K
8: EX-101.SCH XBRL Schema -- flt-20220630 XSD 155K
84: JSON XBRL Instance as JSON Data -- MetaLinks 413± 645K
85: ZIP XBRL Zipped Folder -- 0001628280-22-022016-xbrl Zip 766K
Alan,
we’re pleased to provide you with a review of your 2022 Compensation.
1.Performance-Based Stock Option Grant. In October 2021, the Compensation Committee provided you with a one-time, outsized grant of 30,000 performance-based stock options. This grant could allow you to make an incremental $5M. You and I will work together to determine the 3-year performance criteria. The options will be dependent on you achieving the criteria we establish and you must be employed at the time of vest. Vesting is 3-year cliff and based on 2022, 2023 and 2024 performance.
2.2022 Go-Forward Compensation: Your 2022 Compensation will be as follows.
a.2022
Cash. Your cash compensation for 2022 will be:
i.Base Salary: Your 2022 base salary will increase to $450,000 USD annualized.
ii.Bonus: Your 2022 bonus target will remain at 75% of your base salary or $337,500. We will formalize your 2022 PBOs over the next month.
iii.EPS Grant: For 2022, you have been awarded 1,486 restricted shares ($335,000 in grant date value). These shares will vest one year from the date of grant, if we achieve a specific 2022 Cash EPS Target (macro-adjusted and as revised for the pro-forma impact of acquisitions). We will formalize the
target over the next few weeks.
b.2022 New Equity Grants. The Compensation Committee approved an increase in your annual performance-based restricted stock grant and your annual stock option grant. You have been awarded three new equity grants as follows:
i.Performance-Based Restricted Stock: You were granted 5,323 new performance-based restricted shares ($1,200,000 in GDV) which have a one-year performance period and a three-year vest, upon achievement of a specific 2022 macro-adjusted net revenue. We will work together to formalize the target over the next few weeks. Assuming performance, your shares will vest in equal increments in early 2023, 2024 and 2025 (assuming continued employment). If you do not achieve
the target, all shares will be forfeited.
ii.Stock Option Grant: You were also granted 18,352 new stock options with an exercise price of $225.45 ($1,200,000 in GDV). These shares will time vest evenly over 4 years. You must be employed in order for the shares to vest.
iii.Retention Stock Option Grant. We recognize the stock price has been challenged over the last several years and that you forfeited compensation in 2020, therefore, the Compensation Committee agreed to grant you an additional 18,352 new stock options with an exercise price of $225.45 ($1,200,000 in GDV). This is a one-time grant. These shares will time vest evenly over 4 years. You must be employed in order for the shares to vest.
1
Dates Referenced Herein and Documents Incorporated by Reference
